HOT RADAR
llmHEAT 10.7°

AI CURATED HOT STORY · 11/22/2026

Glucose-Powered Implant Restores Blood Sugar Control in Diabetic Rats

1 reports archived1 independent sourcesupdated 11/22/2026, 14:21:47
Synthesis & Latest Updates
1 Sources Cross-Validated

Researchers from the National University of Singapore and Nanjing University of Posts and Telecommunications report in Nature a glucose-powered implant, NeuroAxis, that electrically stimulates the vagus nerve to engage cholinergic anti-inflammatory and neuroimmune regulation for closed-loop glucose control. Type 2 diabetic rats approached healthy glucose levels within two weeks, while type 1 rats regained glycemic control after eight weeks, with evidence of pancreatic beta-cell proliferation. The work is the first to use glucose as both an energy source and a metabolic sensing signal in a battery-free, self-regulating neurostimulation system.

LATEST/Researchers from the National University of Singapore and Nanjing University of Posts and Telecommunications report in Nature a glucose-powered implant, NeuroAxis, that electrically stimulates the vagus nerve to engage cholinergic anti-inflammatory and neuroimmune regulation for closed-loop glucose control. Type 2 diabetic rats approached healthy glucose levels within two weeks, while type 1 rats regained glycemic control after eight weeks, with evidence of pancreatic beta-cell proliferation. The work is the first to use glucose as both an energy source and a metabolic sensing signal in a battery-free, self-regulating neurostimulation system.

Hourly heat curve

6 fully observed hours
Now
10.7
Peak
11.815:00
24h change
–

The line compares only sources observed throughout; gap hours are interpolated to keep the trend continuous.

Coverage timeline

Total 1 reports · Latest first
  1. 量子位官网T2·78 pts
    • NeuroAxis uses glucose-generated power to drive vagus nerve stimulation, enabling battery-free closed-loop glucose control
    • Type 2 diabetic rats neared normal glucose within two weeks; type 1 rats regained control after eight weeks with beta-cell proliferation
    • Mechanism involves vagus-mediated cholinergic anti-inflammatory pathways and regulation of appetite and energy intake